SO2F-Sarcosine oxidase

Added to your cart

SO2F-Sarcosine oxidase

Cart subtotal: £0.00

View cart (0) Checkout

#SKU SO2F

Get in touch to purchase this product

Contact our team of experts to discuss your requirements

Contact our expert team

Product Details

Creatinine is a waste product produced by muscle metabolism which is normally filtered out of the blood by the kidneys. Abnormal Creatinine levels in blood could indicate a decline in renal function. Creatinase, Creatininase and Sarcosine Oxidase when coupled with Peroxidase are used in Biosensor and Clinical Chemistry applications for the determination of Creatinine and Creatine. Why BBI? + Proven performance – Our products have been used in both biosensor and clinical chemistry applications
SO2F

More information

Attributes

Description

  • Abbreviations
  • SO2F
  • Lead Time
  • 4 weeks
  • Storage
  • Store desiccated at -15°C or below. Allow to come
  • Shelf Life
  • Please enquire
  • Manufacturer Country
  • UK
  • Source
  • Recombinant Escherichia coli
  • Activity
  • ≥20 U/mg material
  • EC Number
  • 1.5.3.1
  • Systematic Name
  • Sarcosine: oxygen 2-oxidoreductase (demethylating)
  • Unit Definition
  • That amount of enzyme which produces one micromole of formaldehyde per minute at 37C and pH 7.7.

Technical Documents

Product Specification (54.89KB)

Product Information (238.31KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox